pioglitazone has been researched along with 8-hydroxy-2'-deoxyguanosine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirasawa, Y; Ito, M; Kawasaki, Y; Kyuki, K; Matsui, Y; Nagamatsu, T; Sakai, T; Toyoshi, T; Yabuki, SY; Yamane, K | 1 |
| Kaneto, H; Kato, K; Kawashima, S; Matsuhisa, M; Matsuoka, TA; Shimomura, I; Tochino, Y; Yamamoto, K; Yamamoto, T | 1 |
| Ahmet, D; Cigdem, E; Ece, H; Hakan, E; Oktay, TM; Yuksel, K | 1 |
| Baker, L; Clark-Matott, J; Dunlop, SR; Elm, J; Emborg, M; Graebner, AK; Kamp, C; Morgan, JC; Ravina, B; Ross, GW; Sharma, S; Simon, DK; Simuni, T | 1 |
1 trial(s) available for pioglitazone and 8-hydroxy-2'-deoxyguanosine
| Article | Year |
|---|---|
Peripheral Biomarkers of Parkinson's Disease Progression and Pioglitazone Effects.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Aged; Biomarkers; Deoxyguanosine; Disease Progression; Female; Gene Expression; Humans; Hypoglycemic Agents; Inflammation; Interleukin-6; Male; Middle Aged; Oxidative Stress; Parkinson Disease; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Pioglitazone; Thiazolidinediones; Transcription Factors; Treatment Failure | 2015 |
3 other study(ies) available for pioglitazone and 8-hydroxy-2'-deoxyguanosine
| Article | Year |
|---|---|
Pioglitazone improves obesity type diabetic nephropathy: relation to the mitigation of renal oxidative reaction.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Blood Glucose; Cholesterol; Cystatin C; Cystatins; Diabetic Nephropathies; Glycated Hemoglobin; Guanine; Hypoglycemic Agents; Insulin; Kidney; Malondialdehyde; Obesity; Oxidation-Reduction; Phospholipids; Pioglitazone; Rats; Rats, Zucker; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Thiazolidinediones; Transforming Growth Factor beta; Triglycerides | 2008 |
Effect of alogliptin, pioglitazone and glargine on pancreatic β-cells in diabetic db/db mice.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Blood Glucose; Body Weight; Deoxyguanosine; Dipeptidyl-Peptidase IV Inhibitors; Glucagon-Like Peptide-1 Receptor; Glycated Hemoglobin; Hypoglycemic Agents; Insulin; Insulin Glargine; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Insulin, Long-Acting; Maf Transcription Factors, Large; Mice; Mice, Inbred C57BL; Pioglitazone; Piperidines; Receptors, Glucagon; Thiazolidinediones; Triglycerides; Uracil | 2011 |
Use of oral antidiabetic drugs (metformin and pioglitazone) in diabetic patients with breast cancer: how does it effect serum Hif-1 alpha and 8Ohdg levels?
Topics: 8-Hydroxy-2'-Deoxyguanosine; Administration, Oral; Blood Glucose; Breast Neoplasms; Case-Control Studies; Deoxyguanosine; Diabetes Mellitus, Type 2; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Hypoxia-Inducible Factor 1, alpha Subunit; Insulin; Metformin; Pioglitazone; Prognosis; Thiazolidinediones | 2012 |